Table 4 Health economic savings, EUR per patient initiating treatment per year
From: Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
Chronic migraine | High-frequency episodic migraine | Low-frequency episodic migraine | ||||
|---|---|---|---|---|---|---|
Baseline | Savings | Baseline | Savings | Baseline | Savings | |
Attack medication | 350 | 87 | 245 | 79 | 130 | 42 |
Preventive medication | 1,808 | 776 | 178 | 102 | 164 | 97 |
Healthcare resource use | 1,007 | 317 | 287 | 83 | 150 | 36 |
Total | 3,164 | 1,179 | 709 | 264 | 444 | 175 |